Inner Mongolia Furui Medical Science Future Growth
Future criteria checks 5/6
Inner Mongolia Furui Medical Science is forecast to grow earnings and revenue by 43.1% and 32.2% per annum respectively while EPS is expected to grow by 41.6% per annum.
Key information
43.1%
Earnings growth rate
41.6%
EPS growth rate
Pharmaceuticals earnings growth | 19.2% |
Revenue growth rate | 32.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 2,165 | 288 | 56 | N/A | 3 |
12/31/2024 | 1,564 | 200 | 50 | N/A | 1 |
3/31/2024 | 1,234 | 132 | N/A | N/A | N/A |
12/31/2023 | 1,153 | 103 | N/A | N/A | N/A |
9/30/2023 | 1,097 | 110 | 99 | 282 | N/A |
6/30/2023 | 1,084 | 109 | 148 | 268 | N/A |
3/31/2023 | 1,042 | 102 | 109 | 223 | N/A |
12/31/2022 | 1,009 | 98 | 99 | 189 | N/A |
9/30/2022 | 1,017 | 98 | 120 | 197 | N/A |
6/30/2022 | 960 | 86 | 90 | 174 | N/A |
3/31/2022 | 931 | 92 | 134 | 221 | N/A |
1/1/2022 | 898 | 95 | 143 | 223 | N/A |
9/30/2021 | 848 | 90 | 125 | 220 | N/A |
6/30/2021 | 832 | 89 | 83 | 201 | N/A |
3/31/2021 | 780 | 64 | 60 | 169 | N/A |
12/31/2020 | 808 | 62 | 90 | 200 | N/A |
9/30/2020 | 817 | 50 | 79 | 171 | N/A |
6/30/2020 | 808 | 42 | 144 | 210 | N/A |
3/31/2020 | 862 | 47 | 213 | 278 | N/A |
12/31/2019 | 832 | 43 | 190 | 256 | N/A |
9/30/2019 | 858 | 1 | 176 | 269 | N/A |
6/30/2019 | 865 | 3 | 93 | 178 | N/A |
3/31/2019 | 866 | 32 | 24 | 122 | N/A |
12/31/2018 | 867 | 35 | -16 | 78 | N/A |
9/30/2018 | 824 | 71 | 23 | 84 | N/A |
6/30/2018 | 799 | 70 | 80 | 138 | N/A |
3/31/2018 | 844 | 63 | 92 | 138 | N/A |
12/31/2017 | 823 | 61 | N/A | 132 | N/A |
9/30/2017 | 882 | 117 | N/A | 106 | N/A |
6/30/2017 | 886 | 117 | N/A | 109 | N/A |
3/31/2017 | 858 | 121 | N/A | 114 | N/A |
12/31/2016 | 827 | 121 | N/A | 149 | N/A |
9/30/2016 | 709 | 100 | N/A | 189 | N/A |
6/30/2016 | 671 | 99 | N/A | 143 | N/A |
3/31/2016 | 608 | 92 | N/A | 167 | N/A |
12/31/2015 | 604 | 92 | N/A | 158 | N/A |
9/30/2015 | 649 | 90 | N/A | 101 | N/A |
6/30/2015 | 668 | 108 | N/A | 127 | N/A |
3/31/2015 | 634 | 90 | N/A | 72 | N/A |
12/31/2014 | 646 | 87 | N/A | 51 | N/A |
9/30/2014 | 567 | 39 | N/A | 23 | N/A |
6/30/2014 | 564 | 15 | N/A | 36 | N/A |
3/31/2014 | 533 | 7 | N/A | 27 | N/A |
12/31/2013 | 523 | 5 | N/A | 28 | N/A |
9/30/2013 | 516 | 6 | N/A | 25 | N/A |
6/30/2013 | 464 | 18 | N/A | 24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300049's forecast earnings growth (43.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 300049's earnings (43.1% per year) are forecast to grow faster than the CN market (24.1% per year).
High Growth Earnings: 300049's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300049's revenue (32.2% per year) is forecast to grow faster than the CN market (14.7% per year).
High Growth Revenue: 300049's revenue (32.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300049's Return on Equity is forecast to be high in 3 years time